Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer's disease

Imaging biomarkers for Alzheimer's disease are desirable for improved diagnosis and monitoring, as well as drug discovery. Automated image-based classification of individual patients could provide valuable diagnostic support for clinicians, when considered alongside cognitive assessment scores. We investigate the value of combining cross-sectional and longitudinal multi-region FDG-PET information for classification, using clinical and imaging data from the Alzheimer's Disease Neuroimaging Initiative. Whole-brain segmentations into 83 anatomically defined regions were automatically generated for baseline and 12-month FDG-PET images. Regional signal intensities were extracted at each timepoint, as well as changes in signal intensity over the follow-up period. Features were provided to a support vector machine classifier. By combining 12-month signal intensities and changes over 12 months, we achieve significantly increased classification performance compared with using any of the three feature sets independently. Based on this combined feature set, we report classification accuracies of 88% between patients with Alzheimer's disease and elderly healthy controls, and 65% between patients with stable mild cognitive impairment and those who subsequently progressed to Alzheimer's disease. We demonstrate that information extracted from serial FDG-PET through regional analysis can be used to achieve state-of-the-art classification of diagnostic groups in a realistic multi-centre setting. This finding may be usefully applied in the diagnosis of Alzheimer's disease, predicting disease course in individuals with mild cognitive impairment, and in the selection of participants for clinical trials.

[1]  Corinna Cortes,et al.  Support-Vector Networks , 1995, Machine Learning.

[2]  Albert Gjedde,et al.  Data-driven intensity normalization of PET group comparison studies is superior to global mean normalization , 2009, NeuroImage.

[3]  R. Petersen Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[4]  J. Hoffman,et al.  FDG PET imaging in patients with pathologically verified dementia. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  Nick C Fox,et al.  Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. , 1997, Computer methods and programs in biomedicine.

[6]  Moo K. Chung,et al.  Spatially augmented LPboosting for AD classification with evaluations on the ADNI dataset , 2009, NeuroImage.

[7]  Yong Xia,et al.  Genetic algorithm-based PCA eigenvector selection and weighting for automated identification of dementia using FDG-PET imaging. , 2008, Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference.

[8]  Alexander Hammers,et al.  Three‐dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe , 2003, Human brain mapping.

[9]  Daniel Rueckert,et al.  Regional Analysis of FDG-PET for the Classification of Alzheimers Disease , 2011, MIUA.

[10]  Daniel Rueckert,et al.  Random Forest-Based Manifold Learning for Classification of Imaging Data in Dementia , 2011, MLMI.

[11]  Colin Studholme,et al.  An overlap invariant entropy measure of 3D medical image alignment , 1999, Pattern Recognit..

[12]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[13]  Vikas Singh,et al.  Predictive markers for AD in a multi-modality framework: An analysis of MCI progression in the ADNI population , 2011, NeuroImage.

[14]  Daoqiang Zhang,et al.  Multimodal classification of Alzheimer's disease and mild cognitive impairment , 2011, NeuroImage.

[15]  Daniel Rueckert,et al.  Regional analysis of FDG-PET for use in the classification of Alzheimer'S Disease , 2011, 2011 IEEE International Symposium on Biomedical Imaging: From Nano to Macro.

[16]  Sébastien Ourselin,et al.  Brain MAPS: An automated, accurate and robust brain extraction technique using a template library , 2011, NeuroImage.

[17]  Nick C Fox,et al.  The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease , 2011 .

[18]  D. Perani,et al.  Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. , 2005, Archives of neurology.

[19]  Kathryn Ziegler-Graham,et al.  Forecasting the global burden of Alzheimer’s disease , 2007, Alzheimer's & Dementia.

[20]  E. Reiman,et al.  Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias , 2008, Journal of Nuclear Medicine.

[21]  Sibylle Ziegler,et al.  Integrated simultaneous whole-body MR/PET: First comparison between MR/PET and PET/CT in patients , 2011 .

[22]  Alexander Hammers,et al.  Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18 , 2008, Psychiatry Research: Neuroimaging.

[23]  Chih-Jen Lin,et al.  LIBSVM: A library for support vector machines , 2011, TIST.

[24]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[25]  et al.,et al.  Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI) , 2009, NeuroImage.

[26]  Anders M. Dale,et al.  Reliability in multi-site structural MRI studies: Effects of gradient non-linearity correction on phantom and human data , 2006, NeuroImage.

[27]  W. Jagust,et al.  The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core , 2010, Alzheimer's & Dementia.

[28]  J. Hodges,et al.  Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment , 2003, Annals of neurology.

[29]  Marie Chupin,et al.  Automatic classi fi cation of patients with Alzheimer ' s disease from structural MRI : A comparison of ten methods using the ADNI database , 2010 .

[30]  J. Ramírez,et al.  Feature selection using factor analysis for Alzheimer's diagnosis using 18F-FDG PET images. , 2010, Medical physics.

[31]  Elizabeth Johnson,et al.  O1-02-01 Forecasting the global prevalence and burden of Alzheimer’s disease , 2007, Alzheimer's & Dementia.

[32]  Alexander Hammers,et al.  SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging , 2009, NeuroImage.

[33]  Nick C Fox,et al.  The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods , 2008, Journal of magnetic resonance imaging : JMRI.

[34]  Arthur W. Toga,et al.  A Probabilistic Atlas of the Human Brain: Theory and Rationale for Its Development The International Consortium for Brain Mapping (ICBM) , 1995, NeuroImage.

[35]  et al.,et al.  Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET , 2002, NeuroImage.

[36]  Michael Weiner,et al.  Comparison of phantom and registration scaling corrections using the ADNI cohort , 2009, NeuroImage.

[37]  D. Perani,et al.  MCI conversion to dementia and the APOE genotype , 2004, Neurology.

[38]  Linda S Hynan,et al.  Clinical criteria for the diagnosis of Alzheimer disease: still good after all these years. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[39]  Alexander Hammers,et al.  Automatic segmentation of the hippocampus and the amygdala driven by hybrid constraints: Method and validation , 2009, NeuroImage.

[40]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[41]  Stewart Young,et al.  Metabolic heterogeneity in ADNI PET subjects , 2009 .

[42]  Jyrki Lötjönen,et al.  Measurement of hippocampal atrophy using 4D graph-cut segmentation: Application to ADNI , 2010, NeuroImage.

[43]  R. Leker,et al.  Anticardiolipin Antibodies—Reply , 1999 .

[44]  Michael W. Weiner,et al.  Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: Findings from the Alzheimer's Disease Neuroimaging Initiative , 2010, NeuroImage.

[45]  Nick C Fox,et al.  Automated Hippocampal Segmentation by Regional Fluid Registration of Serial MRI: Validation and Application in Alzheimer's Disease , 2001, NeuroImage.

[46]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup , 2011 .

[47]  C. Grady,et al.  Neural-network classification of normal and Alzheimer's disease subjects using high-resolution and low-resolution PET cameras. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[48]  Satoshi Minoshima,et al.  Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation , 2001, Annals of neurology.

[49]  G. Alexander,et al.  Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. , 2001, JAMA.

[50]  M. Bobinski,et al.  Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET) , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Haiying Liu,et al.  A Generic Framework for Non-rigid Registration Based on Non-uniform Multi-level Free-Form Deformations , 2001, MICCAI.

[52]  J. Ramírez,et al.  Feature selection using factor analysis for Alzheimer's diagnosis using 18F-FDG PET images. , 2010, Medical physics.

[53]  A. Convit,et al.  Reduced hippocampal metabolism in MCI and AD , 2005, Neurology.

[54]  W. Jagust,et al.  Performance of FDG PET for Detection of Alzheimer’s Disease in Two Independent Multicentre Samples (NEST-DD and ADNI) , 2009, Dementia and Geriatric Cognitive Disorders.

[55]  Daniel Rueckert,et al.  Improving intersubject image registration using tissue-class information benefits robustness and accuracy of multi-atlas based anatomical segmentation , 2010, NeuroImage.

[56]  Daniel Rueckert,et al.  Automatic morphometry in Alzheimer's disease and mild cognitive impairment☆☆☆ , 2011, NeuroImage.

[57]  Daniel Rueckert,et al.  Nonrigid registration using free-form deformations: application to breast MR images , 1999, IEEE Transactions on Medical Imaging.

[58]  Daniel Rueckert,et al.  Automatic segmentation of brain MRIs of 2-year-olds into 83 regions of interest , 2008, NeuroImage.

[59]  Alan C. Evans,et al.  A nonparametric method for automatic correction of intensity nonuniformity in MRI data , 1998, IEEE Transactions on Medical Imaging.